ERBB2 and acute myeloid leukemia: Specific CsA responses at the phosphoproteome level include the down-regulation of pathways that control hematopoietic differentiation and immunity (Granzyme B, ErbB2, NGF, Rho GTPase, AML) being consistent with known effects of CsA as an immunosuppressant (Zhou et al. 2015) and inducer of apoptosis (Koppelstaetter et al. 2018).